Clinical outcomes of transarterial chemoembolization combined with durvalumab for advanced and metastatic biliary tract cancer

Background This study aimed to evaluate the safety and efficacy of TACE combined with durvalumab for treating advanced and metastatic BTC. Research design and methods: Data were collected retrospectively from a single center. The TACE procedures were performed 1 to 19 times, with repetitions occurri...

Descripción completa

Detalles Bibliográficos

Autores principales:	Yuefeng Hu, Jian Wei, Xuedong Sun, Guang Chen, Tianhao Su, Zeran Yang, Xu Lu, Long Jin
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Taylor & Francis Group 2025-12-01
Colección:	Future Science OA
Materias:	Biliary tract cancer immune checkpoint inhibitors transarterial chemoembolization durvalumab Immunotherapy
Acceso en línea:	https://www.tandfonline.com/doi/10.1080/20565623.2025.2526947
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!